The skin barrier effectively blocks molecules larger than about 500 daltons from penetrating to the bloodstream
[PMID: 39976950] PubMed record related to this compound for laboratory literature review
Small-molecule GLP-1RA litigation over the coming decade will likely generate more numerous, more independently contested patent challenges than peptide GLP-1RA litigation has
J., Dwyer, C
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Frederich R, Wiviott SD, Hoffman EB, Cavender MA, Udell JA, Desai NR, Mosenzon O, McGuire DK, Ray KK, Leiter LA, Raz I, Committee S-TS, and Investigators